Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7558589rdf:typepubmed:Citationlld:pubmed
pubmed-article:7558589lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:7558589lifeskim:mentionsumls-concept:C0001271lld:lifeskim
pubmed-article:7558589lifeskim:mentionsumls-concept:C0078238lld:lifeskim
pubmed-article:7558589lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:7558589lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7558589lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7558589lifeskim:mentionsumls-concept:C0597551lld:lifeskim
pubmed-article:7558589pubmed:issue6lld:pubmed
pubmed-article:7558589pubmed:dateCreated1995-11-6lld:pubmed
pubmed-article:7558589pubmed:abstractTextThe solution structure of a synthetic 22-amino acid peptide (P1) corresponding to the extreme C-terminal end and one of the F-actin binding sites of villin has been determined by 1H NMR and CD spectroscopy. The structure of this peptide was compared to that of a peptide in which lysine to glutamic acid substitutions were introduced at positions 17 and 19 (P11), abolishing F-actin binding. Both peptides are largely unstructured in aqueous solution. Changes observed in the NMR and CD spectra of both peptides are consistent with alpha-helix formation in trifluoroethanol/water mixtures. A set of 189 interproton distances derived from nuclear Overhauser enhancement (NOE) measurements, 17 phi-angle constraints obtained from 3JNH alpha coupling constants, as well as about 10 N ... O distance restraints deduced from amide proton exchange kinetics with deuterium, were used for the structure determination. The three-dimensional structure of P1 and P11 is characterized by two helical regions, one extending from residues 2 to 5 and a second covering residues 7 to 17. The central fragment, ranging from Leu-7 to Leu-15, is more stable. The C-terminal residues are less structured, particularly within peptide P11. The significance of these structural results is discussed in relation to the biological activity of villin.lld:pubmed
pubmed-article:7558589pubmed:languageenglld:pubmed
pubmed-article:7558589pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7558589pubmed:citationSubsetIMlld:pubmed
pubmed-article:7558589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7558589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7558589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7558589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7558589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7558589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7558589pubmed:statusMEDLINElld:pubmed
pubmed-article:7558589pubmed:monthJunlld:pubmed
pubmed-article:7558589pubmed:issn0367-8377lld:pubmed
pubmed-article:7558589pubmed:authorpubmed-author:GoethalsMMlld:pubmed
pubmed-article:7558589pubmed:authorpubmed-author:LouvardDDlld:pubmed
pubmed-article:7558589pubmed:authorpubmed-author:Vandekerckhov...lld:pubmed
pubmed-article:7558589pubmed:authorpubmed-author:RoseTTlld:pubmed
pubmed-article:7558589pubmed:authorpubmed-author:FriederichEElld:pubmed
pubmed-article:7558589pubmed:authorpubmed-author:DelepierreMMlld:pubmed
pubmed-article:7558589pubmed:authorpubmed-author:SimenelCClld:pubmed
pubmed-article:7558589pubmed:issnTypePrintlld:pubmed
pubmed-article:7558589pubmed:volume45lld:pubmed
pubmed-article:7558589pubmed:ownerNLMlld:pubmed
pubmed-article:7558589pubmed:authorsCompleteYlld:pubmed
pubmed-article:7558589pubmed:pagination574-86lld:pubmed
pubmed-article:7558589pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:meshHeadingpubmed-meshheading:7558589-...lld:pubmed
pubmed-article:7558589pubmed:year1995lld:pubmed
pubmed-article:7558589pubmed:articleTitleConformational behaviour of a synthetic peptide of the C-terminus of villin that interacts with actin: an NMR, CD and stimulated annealing study.lld:pubmed
pubmed-article:7558589pubmed:affiliationNMR Laboratory, Pasteur Institute, CNRS URA 1129, Paris, France.lld:pubmed
pubmed-article:7558589pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7558589pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7558589lld:pubmed